ANITA DESWAL to Phosphodiesterase 5 Inhibitors
This is a "connection" page, showing publications ANITA DESWAL has written about Phosphodiesterase 5 Inhibitors.
Connection Strength
0.518
-
Response to Letter Regarding Article, ?Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction?. Circ Heart Fail. 2015 Jul; 8(4):840.
Score: 0.114
-
Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction. Circ Heart Fail. 2015 May; 8(3):533-41.
Score: 0.112
-
Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail. 2014 Jan; 7(1):123-30.
Score: 0.101
-
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2013 Mar 27; 309(12):1268-77.
Score: 0.097
-
PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design. Circ Heart Fail. 2012 Sep 01; 5(5):653-9.
Score: 0.094